Determination of nucleosidic/tidic reverse transcriptase inhibitors in plasma and cerebrospinal fluid by ultra-high-pressure liquid chromatography coupled with tandem mass spectrometry | Zendy

Perrine Courlet | Zendy; Dany Spaggiari | Zendy; Matthias Cavassini | Zendy; Renaud Du Pasquier | Zendy; Susana Alves Saldanha | Zendy; Thierry Buclin | Zendy; Catia Marzolini | Zendy; Chantal Csajka | Zendy; Laurent A. Décosterd | Zendy

Open Access

Determination of nucleosidic/tidic reverse transcriptase inhibitors in plasma and cerebrospinal fluid by ultra-high-pressure liquid chromatography coupled with tandem mass spectrometry

Author(s) -

Perrine Courlet,

Dany Spaggiari,

Matthias Cavassini,

Renaud Du Pasquier,

Susana Alves Saldanha,

Thierry Buclin,

Catia Marzolini,

Chantal Csajka,

Laurent A. Décosterd

Publication year - 2018

Publication title -

clinical mass spectrometry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.473

H-Index - 8

eISSN - 2376-9998

pISSN - 2213-8005

DOI - 10.1016/j.clinms.2018.04.001

Subject(s) - abacavir , zidovudine , emtricitabine , lamivudine , nucleoside reverse transcriptase inhibitor , therapeutic drug monitoring , reverse transcriptase inhibitor , context (archaeology) , efavirenz , chemistry , pharmacology , chromatography , medicine , human immunodeficiency virus (hiv) , drug , virology , viral load , antiretroviral therapy , virus , biology , viral disease , hepatitis b virus , paleontology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research